Stockscreener 앱 받기
4.53
5.62%
-0.27
전일 마감가:
$4.80
열려 있는:
$4.79
하루 거래량:
1.73M
Relative Volume:
0.90
시가총액:
$512.16M
수익:
$1.89B
순이익/손실:
$-496.52M
주가수익비율:
-0.9517
EPS:
-4.7598
순현금흐름:
$1.40M
1주 성능:
-6.98%
1개월 성능:
+25.48%
6개월 성능:
+30.55%
1년 성능:
-40.71%
1일 변동 폭
$0.00
$0.00
1주일 범위
$4.36
$4.9499
52주 변동 폭
$2.095
$7.915
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HNGE, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.53 | 512.16M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
318.18 | 51.52B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
67.16 | 12.24B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
58.88 | 11.65B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
111.71 | 9.01B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
103.75 | 8.58B | 1.34B | 230.70M | 440.96M | 2.6695 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-07-23 | 다운그레이드 | Citigroup | Buy → Sell |
| 2026-06-30 | 다운그레이드 | Truist | Buy → Hold |
| 2026-02-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Evolent program flags low-value regimen years ahead of failed clinical trial - RamaOnHealthcare
Morgan Stanley slips under 5% in Evolent Health (NYSE: EVH) - Stock Titan
EVH6495551 Latest News and Headlines - TradingView
Evolent Health (EVH) President Daniel Mccarthy Sells 65,892 Shar - GuruFocus
Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460 - Bitget
EVH6495551 Bond Yield and Price — FINRA:EVH6495551 - TradingView
Evolent Health (EVH) Institutional Ownership 2026 $EVH - MarketBeat
Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan
EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - quiverquant.com
EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus
EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com
Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha
Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - TradingView
EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Nigeria
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com South Africa
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com India
Truist cuts Evolent Health stock price target on execution risks - Investing.com
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Canada
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com UK
Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com
Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com
EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Evolent Health Price Target Cut to $6.00/Share From $7.00 by Canaccord Genuity - Moomoo
Citi Upgrades Evolent Health(EVH.US) to Buy Rating, Cuts Target Price to $6 - Moomoo
Evolent Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:EVH) 2026-08-10 - Seeking Alpha
EVH Looks 60.0% Undervalued on GF Value™ Despite Profitability C - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Nigeria
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com South Africa
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Australia
EVH Maintained by Canaccord Genuity -- Price Target Lowered to $6.00 - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook - Investing.com
Canaccord cuts Evolent Health stock price target on margin outlook - Investing.com India
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Canada
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com UK
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Evolent Health Inc 주식 (EVH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Daniel McCarthy | Officer |
Aug 26 '26 |
Proposed Sale |
4.97 |
65,892 |
327,476 |
0 |
| Springstubb Brendan B | Director |
Nov 18 '25 |
Buy |
3.82 |
10,000 |
38,199 |
58,821 |
2.37%
8.34%
자본화:
|
볼륨(24시간):